Found 41 matching trials
High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC PHASE2 This is a Phase II, single-arm, open-label, multicenter clinical study aime...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC PHASE2 In this study, patients with EGFR/ALK wild-type, resectable locally advance...
Show More Location
Department of Thoracic Oncology, Hangzhou Cancer Hospital
Learn More & Join Trial
Tracheobronchial Bioengineering Using Aortic Matrices for Airway Reconstruction N/A A technic of tracheal, carinal or bronchial transplantation using a stented...
Show More Location
Hopital AVICENNES Service de Chirurgie Thoracique
Learn More & Join Trial
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients NA This multicenter prospective clinical study focuses on elderly patients wit...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage NA The main purpose of this study is to compare the effects of neoadjuvant wit...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC NA \*Study Overview This study is investigating a surgical approach for patien...
Show More Location
Shanghai General Hospital Thoracic Surgery Department
Learn More & Join Trial
The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for Patients With Unresectable Stage IIIB-IIIC NSCLC: A Prospective, Single-Arm, Phase II Study PHASE2 This study aimed to evaluate the conversion rate to curative-intent treatme...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function NA This clinical study is evaluating different treatment options for patients ...
Show More Status
Active Not Recruiting
Location
Lithuanian University of Health Sciences Kaunas Clinics
Learn More & Join Trial
A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC PHASE2 Evaluate the efficacy and safety of neoadjuvant furmonertinib combined with...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China PHASE2 Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Show More Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Learn More & Join Trial